Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)

The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). The objective of the NCI's ESI MERIT Award is to allow eligible investigators the opportunity to obtain up to 7 years of support in two segments. Key aspects of this opportunity include: • Support for Early Stage Investigators (ESIs) • Up to 7 years of funding in two segments • Opportunity for flexibility and creativity in research • Eligibility for various types of organizations, including non-profits, educational institutions, and small businesses • Focus on cancer research, including cancer cause and prevention, detection and diagnosis, treatment, biology, and control.